Related Experiment Videos
Platelet-activating factor inhibits (Na+,K+) ATPase activity in rat brain
R E Catalán1, A M Martínez, M D Aragonés
1Departamento de Biologia Molecular, Universidad Autónoma de Madrid, Spain.
Neuroscience Research
|March 1, 1994
Summary
Platelet-activating factor (PAF) inhibits (Na+,K+)-ATPase activity in rat brain cortex. This effect, mediated by specific receptors and dependent on calcium, suggests a role for PAF in pathological conditions like ischemia.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Platelet-activating factor (PAF) is a potent lipid mediator involved in various physiological and pathological processes.
- The (Na+,K+)-ATPase enzyme is crucial for maintaining cellular ion balance and neuronal function in the brain.
Purpose of the Study:
- To investigate the effect of PAF on (Na+,K+)-ATPase activity in the rat cerebral cortex.
- To elucidate the potential mechanisms underlying PAF's action on this critical enzyme.
Main Methods:
- Enzyme activity assays were performed on rat cerebral cortex homogenates.
- Dose- and time-dependency of PAF effects were evaluated.
- The role of PAF receptors and calcium ions was assessed using specific antagonists and ion omission.
Main Results:
- PAF, but not lysoPAF, significantly inhibited (Na+,K+)-ATPase activity in a dose- and time-dependent manner.
- The inhibitory effect of PAF was blocked by the PAF antagonist PCA-4248, suggesting receptor mediation.
- Removal of external calcium increased basal enzyme activity and abolished the inhibitory effect of PAF.
Conclusions:
- PAF inhibits (Na+,K+)-ATPase activity in the rat cerebral cortex.
- This inhibition appears to be mediated via specific PAF receptors and is calcium-dependent.
- PAF may play a significant role in cerebral pathophysiology, such as during ischemia, by modulating ATPase activity.